Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs QAAGZX overlap: 57% of top holdings shared

Bottom line

How much do GGHCX and QAAGZX overlap?

57% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 46.0% of GGHCX's assets and 46.5% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 82), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

GGHCXQAAGZX
Weight overlap (top 25)57%
Shared holdings11
Weight in shared holdings46.0%46.5%
Total positions82277
Expense ratio1.07%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings GGHCX and QAAGZX have in common

Holding% of GGHCX% of QAAGZXOverlap
Eli Lilly and Co.10.59%14.06%10.59%
Johnson & Johnson6.76%6.64%6.64%
UnitedHealth Group Inc.6.17%5.88%5.88%
Merck & Co., Inc.4.59%4.00%4.00%
AbbVie Inc.4.03%5.12%4.03%
Gilead Sciences, Inc.3.63%2.79%2.79%
CVS Health Corp.2.52%0.93%0.93%
Cardinal Health, Inc.2.10%1.04%1.04%
Guardant Health, Inc.2.04%1.22%1.22%
Vertex Pharmaceuticals Inc.2.01%2.26%2.01%
Thermo Fisher Scientific Inc.1.55%2.53%1.55%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. BrightSpring Health Services, Inc. — 2.20%
  5. Royalty Pharma PLC — 2.13%
  6. Invesco Private Government Fund — 1.80%
  7. Axsome Therapeutics, Inc. — 1.58%
  8. Edwards Lifesciences Corp. — 1.56%
  9. Invesco Treasury Portfolio — 1.56%
  10. BridgeBio Pharma, Inc. — 1.43%
  11. Waters Corp. — 1.41%
  12. IQVIA Holdings Inc. — 1.32%
  13. U C B S.a. — 1.24%
  14. Ligand Pharmaceuticals Inc. — 1.18%

Only in QAAGZX

  1. Bristol-myers Squibb Co — 2.12%
  2. Abbott Laboratories — 1.91%
  3. Intuitive Surgical Inc — 1.89%
  4. Amgen Inc — 1.80%
  5. Stryker Corp — 1.78%
  6. Elevance Health Inc — 1.54%
  7. Danaher Corp — 1.44%
  8. Natera Inc — 1.44%
  9. Royalty Pharma Plc- Cl A — 0.97%
  10. Tenet Healthcare Corp — 0.94%
  11. Kymera Therapeutics Inc — 0.89%
  12. T. Rowe Price Government Reserve Fund — 0.87%
  13. Protagonist Therapeutics Inc — 0.85%
  14. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeGGHCXQAAGZX
Stocks97.5%96.9%
Cash & short-term funds8.8%0.9%
Preferred stock—2.2%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryGGHCXQAAGZX
US93.5%92.3%
NL3.4%1.0%
GB3.1%1.8%
CH2.7%0.5%
BE1.2%—
DK1.1%0.7%
IE0.6%0.8%
BM—0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GGHCX and QAAGZX overlap?
About 57% by weight. 11 securities appear in both funds' top 25 holdings; they make up 46.0% of GGHCX's assets and 46.5% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and QAAGZX have in common?
The largest shared holdings are Eli Lilly and Co., Johnson & Johnson, UnitedHealth Group Inc., AbbVie Inc., Merck & Co., Inc..
Should I own both GGHCX and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or QAAGZX?
QAAGZX is broader, with 277 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.